Drugs detected in suspected pediatric exposures: a 5-year review.

A 5-year hospital study found pediatric cannabis exposure emergency department detection patterns showing cannabis metabolites among the most frequently identified compounds in children presenting with suspected toxic ingestions. This surveillance data helps inform clinical testing strategies while highlighting the importance of secure household cannabis storage practices.

Read More

Acute toxicity of ADB-CHMINACA – a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome.

A new case series reveals that synthetic cannabinoid toxicity emergency treatment protocols are urgently needed as ADB-CHMINACA causes rapid-onset seizures and encephalopathy. Emergency physicians document severe neurologic complications occurring within minutes of synthetic cannabinoid use, highlighting critical safety differences from natural cannabis.

Read More

Comparison of Perspectives on Cannabis Use Between Emergency Department Patients Who Are Users and Non-users.

A prospective survey study found emergency department patients who use cannabis demonstrate superior knowledge of its effects compared to non-users. This cannabis knowledge emergency department patients research suggests clinicians should tailor educational approaches based on usage status. The findings highlight important knowledge gaps that may inform emergency medicine cannabis counseling strategies.

Read More